The routine exchange of important vaccine development material may have become a victim of the trade war between the U.S. and China. More than a year after a serious H7N9 avian influenza outbreak kicked up in China, the country still hasn’t sent samples of the viral strain to researchers in the U.S. to help them develop vaccines and drugs, according to The New York Times.
Read more